Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients

Journal of Neuroimmunology

Volumn 124, Issue 1-2, 2002, Pages 93-100

  Rajda, Cecilia ^a,b,c   Bencsik, Krisztina ^a   Vécsei L, László ^a   Bergquist, Jonas ^b,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Capillary electrophoresis; Catecholamine; Dopamine; Epinephrine; Lymphocytes; Multiple sclerosis; Norepinephrine; Peripheral blood mononuclear cells

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CAPILLARY ELECTROPHORESIS; CELL ACTIVITY; CELL LEVEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; METABOLITE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; REMISSION;

CATECHOLAMINES; HUMANS; LYMPHOCYTES; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEVERITY OF ILLNESS INDEX;

EID: 0036198826     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00002-4     Document Type: Article

References (46)

1. Mechanisms of central and peripheral T-cell tolerance: Lessons from experimental models of multiple sclerosis
2. Neurotransmitter changes in multiple sclerosis
3. Neurobiochemical aspects of Maprotilin (Ludiomil) action
4. The prevalence of multiple sclerosis in the Hungarian city of Szeged
5. Identification of catecholamines in the immune system by electrospray ionization mass spectrometry
6. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop
7. Measurements of catecholamine-mediated apoptosis of immunocompetent cells
8. Catecholaminergic suppression of immunocompetent cells
9. Nuclear factor-kB is involved in the catecholaminergic suppression of immunocompetent cells
10. Is multiple sclerosis the equivalent of Parkinson's disease for noradrenaline?
11. Immune-neuro-endocrine interactions: Facts and hypotheses
12. Production of peptide hormones and neurotransmitters by the immune system
13. Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils
14. Identification of m3, m4 and m5 subtypes of muscarinic receptor mRNA in human blood mononuclear cells
15. Immunohistochemical and electron-microscopic identification of serotonin, melatonin, and β-endorphin in granules of natural killer cells
16. Adrenergic suppression of peripheral blood T-cell reactivity in the rat is due to activation of peripheral α2-receptors
17. Neural-immune interactions
18. Noradrenergic and peptidergic innervation of lymphoid organs
19. Axonal damage in acute multiple sclerosis lesions
20. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis
21. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice: Roles of NF-kappa B in the activation and differentiation of autoreactive T cells
22. Catecholamines are synthetized by mouse lymphocytes and regulate function of these cells by induction of apoptosis
23. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell
24. Increased high-affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis
25. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
26. Axonal changes in chronic demyelinated cervical spinal cord plaques
27. Catecholamine action and immunologic reactivity
28. Endogenous catecholamine synthesis, metabolism, storage and uptake in human peripheral mononuclear cells
29. Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in patients with multiple sclerosis
30. Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes
31. L-Tyrosine and nicotine induce synthesis of L-DOPA and norepinephrine in human lymphocytes
32. Acetylcholine-induced, calcium-dependent norepinephrine outflow from human peripheral lymphocytes
33. Experimental allergic encephalomyelitis, beta-adrenergic receptors and interferon gamma-secreting cells in beta-adrenergic agonist treated rats
34. Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system
35. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
36. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case of antigen-specific antibody mediation
37. 1-like receptors in the thymus of aged rats: A radioligand binding and autoradiographic study
38. Adrenergic/cholinergic immunomodulation in the rat model - In vivo veritas?
39. The role of norepinephrine and beta-2-adrenergic receptor stimulation in the modulation of Th1, Th2, and B lymphocyte function
40. Dopamine receptors on human T- and B-lymphocytes
41. Expression pattern of activation and adhesion molecules on peripheral blood CD4+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: A serial analysis
42. Norepinephrine inhibits human natural killer cell activity in vitro
43. Axonal transection in the lesions of multiple sclerosis
44. Lymphocyte traffic to the brain
45. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats
46. Beta-adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: A regulatory role for cortisol and interleukin-1